StockWatch
·
Pharmaceuticals
Board Meeting9 Nov 2026, 05:20 pm

Medico Remedies Board Approves Unaudited Q2 FY27 Results & Appoints Cost Auditor

AI Summary

Medico Remedies Ltd announced that its Board of Directors, in a meeting held on November 9, 2026, approved the unaudited standalone financial results for the quarter ended September 30, 2026. The Board also appointed M/s. V. J. Talati & Co. as the Cost Auditors for the financial year ending March 31, 2027. The limited review report on the financial results was also presented. The Board meeting commenced at 4:30 PM and concluded at 5:15 PM.

Key Highlights

  • Unaudited standalone financial results for Q2 FY27 approved.
  • M/s. V. J. Talati & Co. appointed as Cost Auditors for FY27.
  • Limited review report on financial results was submitted.
  • Board meeting held on November 9, 2026.